Pay in 4 interest-free payments of $5.35 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Expected: Skin hydration improves, tone evens, texture softens, redness decreases (particularly with KLOW)
It can have a lower cash price, but a compounded product is not equivalent to Ro's FDA-approved branded medication
Boehringer Ingelheim International GmbH Scope of Report GLP-1 Receptor Agonist Market Analysis by Segments Drug: Semaglutide Exenatide Lixisenatide Liraglutide Dulaglutide Others Route of Administration: Oral Parenteral Indication: Diabetes Obesity Others Distribution Channel: Hospital Pharmacies Retail Pharmacies Online Pharmacies Region: North America Latin America Europe Asia-Pacific Middle East & Africa Bibliography Pharmaceutical Executive
Daz A, Lpez-Grueso R, Gambini J, Monlen D, Mas-Bargues C, Abdelaziz KM, et al
US$ 21.36
US$ 24.83
US$ 24.69
US$ 23.96
US$ 27.61
US$ 27.24
US$ 27.32
US$ 28.47
